title: The evolving role of glycoprotein (GP) IIb/IIIa receptor blockade during percutaneous coronary intervention of saphenous vein bypass grafts.
authors.affiliation: Department of Cardiology, Saint Vincent Catholic Medical Centers, New York, NY, 10011, USA.
authors.forename: David J
authors.initials: DJ
authors.lastname: D'Agate
authors.forename: Snehal
authors.initials: S
authors.lastname: Patel
authors.forename: John T
authors.initials: JT
authors.lastname: Coppola
authors.forename: John A
authors.initials: JA
authors.lastname: Ambrose
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000925:Anticoagulants / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000473:pathology / Q000628:therapy; D023903:Coronary Restenosis / Q000517:prevention & control; D004617:Embolism / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D012501:Saphenous Vein / Q000637:transplantation*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex